-+ 0.00%
-+ 0.00%
-+ 0.00%

AKARI THERAPEUTICS - DEVELOPING AKTX-102 ADC TARGETING CEACAM5 IN MULTIPLE SOLID TUMORS

Reuters·08/18/2026 12:53:39

Please log in to view news